Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2010
10/20/2010CN101863953A Method for separating and preparing Liriope graminifolia saponin A from Liriope graminifolia
10/20/2010CN101863945A American ginseng saponin F6 as well as extraction method and medical application thereof
10/20/2010CN101863927A Palladium coordination compound for antitumor drugs
10/20/2010CN101863926A Antitumor drug palladium coordination compound
10/20/2010CN101863925A Aryl ruthenium (11) composition and preparation method and application thereof
10/20/2010CN101863909A Norcantharidin derivative and activity testing method and application thereof
10/20/2010CN101863901A 2-(substituted phenyl)-2-(4,5,6,7-thiophane[3,2-c] pyridine-5(4H)-group)-N-substitute-acetamide as well as preparation method and application thereof
10/20/2010CN101863898A Thieno pyridinone derivative containing piperazidine and preparation method and applications thereof
10/20/2010CN101863897A New volution compound and preparation method and application thereof
10/20/2010CN101863894A Tanshinone II A derivative and preparation method and application thereof
10/20/2010CN101863887A Matrine derivative and preparation method thereof
10/20/2010CN101863883A Piperidone azine compound with activity of resisting leukemia K562 cell proliferation and preparation method thereof
10/20/2010CN101863882A Method for separation and purification of pepromia pellucida B
10/20/2010CN101863878A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
10/20/2010CN101863867A Derivatives of flavonoids compounds and preparation method and application thereof
10/20/2010CN101863861A Simple and efficient method for preparing paclitaxel analogue Larotaxel
10/20/2010CN101863844A Synthesis method of 6,7-substituted-4-aniline quinazoline
10/20/2010CN101863823A 2-oxindole compounds, and ring-enlargement derivatives, preparation method and application thereof
10/20/2010CN101863786A Water-soluble shikonin naphthazarin oxygen nucleus alkyl derivative and preparation and application methods thereof
10/20/2010CN101862628A Biodegradable microencapsulated capsaicine and preparation method thereof
10/20/2010CN101862501A Medicine bag containing taxus chinensis leaves and taxus chinensis leaf treating and processing devices
10/20/2010CN101862459A Treatment of proliferative diseases using an antisense iap oligomer and chemotherapeutic agent
10/20/2010CN101862457A Degradable macromolecule carrier medicament as well as preparation method and application thereof
10/20/2010CN101862456A Remedy
10/20/2010CN101862448A Immune protection effect of AFP (Alpha Fetoprotein) gene modified dendritic cell tumor vaccine to primary liver cancer genesis and development
10/20/2010CN101862446A SOD (Super Oxide Dismutase) grape health care wine
10/20/2010CN101862423A Preparation method for coix seed oil microemulsion
10/20/2010CN101862395A Tumor curing medicine containing saussurea involucrate and preparation method thereof
10/20/2010CN101862365A Anti-tumour terpene compounds
10/20/2010CN101862360A New application of achyranthes for preparing medicines for preventing and/or treating gastric precancerous lesion and gastric cancer
10/20/2010CN101862356A Antineoplastic medicament extracted from Chinese actinidia roots and preparation method thereof
10/20/2010CN101862345A Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
10/20/2010CN101862339A Use of cryptotanshinone as radiation sensitizing medicament in oncotherapy
10/20/2010CN101862331A New use of methyl liensinine
10/20/2010CN101862327A Application of monascus colors and derivatives in preparing drugs for treating cardiovascular and cerebrovascular diseases
10/20/2010CN101862324A Application of monascus color components and derivatives thereof in fighting cancers
10/20/2010CN101862319A Docetaxel combination for injection and preparation method thereof
10/20/2010CN101862315A Application of disubstituted phenyl biguanide to inducing malignant tumor cell for anoikis
10/20/2010CN101862313A Application of anthracycline compound in preparing anti-breast cancer medicines
10/20/2010CN101862312A New application of 6-gingerol
10/20/2010CN101862233A Drug-delivery endovascular stent and method for treating restenosis
10/20/2010CN101518655B Application of human interleukin-24 gene recombined vector mediated by adenovirus in preparing tumor analgesic medicament
10/20/2010CN101361983B Lung cancer DNA plasmid vaccine and preparation method thereof
10/20/2010CN101342194B Traditional Chinese medicine preparation for treating median or late-stage malignant tumors, chronic hepatitis B, and preparation method thereof
10/20/2010CN101301456B Compound Marsdenia tenacissima capsules
10/20/2010CN101293060B Traditional Chinese medicine for treating cytology specification adenocarcinoma
10/20/2010CN101225106B Short peptide suppressing growth of cancer cell and uses thereof
10/19/2010US7816530 cis- or trans-4-(4-cyclopropylmethyl-piperazin-1-yl)-cyclohexylamine; antiinflammatory and antiproliferative activity; antiviral and anticarcinogenic agent
10/19/2010US7816524 Methods of preparing quinolone analogs
10/19/2010US7816521 1,2,4-benzotriazine-1,4-dioxides
10/19/2010US7816516 Reacting hydroxyalkyl starch (HAS) with the bioactive agent in a medium that includes water; drug-HAS conjugates for treating tumors, arrythmia, infectious diseases; bioavailability; nontoxic solvents; biodrug activity is not inactivated
10/19/2010US7816499 Antibody that binds histone deacetylase; transcription repressor activity and deacetylate cellular substrates; treatment of cell proliferation disease
10/19/2010US7816496 Carbonic anhydrase specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders
10/19/2010US7816403 Administering a thiuram disulfide and a heavy metal ion; activated transcription factor/adenosine cyclic phosphate response element binding protein (atf/creb)
10/19/2010US7816398 Fatty alcohol drug conjugates
10/19/2010US7816377 such as 1-methyl-piperidin-2-carbonsaure-[1-({1-[2-hydroxy-2-(4-phenethylcarbamoyl-thiazol-2-yl)-ethyl]-2-methyl-propyl}-methylcarbamoyl)-2-methyl-butyl]-amide, used for the treatement of adenocarcinoma
10/19/2010US7816365 Amine derivatives
10/19/2010US7816363 Inhibitors of histone deacetylase
10/19/2010US7816359 such as (4-[(4-methyl-1-piperazin-1-ylmethyl)-N-[4-methyl-3-[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide), used as antitumor agents
10/19/2010US7816350 2,6,9-trisubstituted 8-azapurines such as 2-(4-aminocyclohexylamino)-6-benzylamino-9-isopropyl-8-azapurine, used as cyclin-dependent kinase inhibitors, in the treatment of skin disorders, viral infections, cancer, arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, gout
10/19/2010US7816333 nucleosides such as 3',5'-di-O-Benzyl-2'-O,4'-C-ethylene-4-N-benzoylcytidine for treatment of pain, psoriasis, inflammatory disorders, infectious skin disease, skin cancer, Lyme disease, influenza virus, cytomegalovirus, herpes virus, herpes simplex virus, papilloma virus, Epstein Barr virus or HIV
10/19/2010US7816319 Methods and products for manipulating uncoupling protein expression
10/19/2010US7816317 Tripeptide prodrug compounds
10/19/2010US7816097 Nucleic acid sequence coding Mammastatin; protein useful in diagnosis, therapy fo breast cancer ; antigrowth agents
10/19/2010US7815921 Using patient's leukocyte concentration after incubation with colony stimulation factor as evaluative tool in predicting susceptibility to infection, bone marrow and autoimmune diseases after chemotherapeutic treatments
10/19/2010US7815920 Method of preparing an antigen-containing formulation
10/19/2010US7815915 Mixture of human papillomavirus virus-like particles
10/19/2010US7815914 methods of identifying susceptibility of cells to reovirus infection by measuring constitutive ras-MAP signaling; provides for reovirus treatment of mammals to treat proliferative disorders including breast tumors, a subset of tumors in which mutation of ras gene is not believed to play significant role
10/19/2010US7815910 Antigen and adjuvant of immunity, a surfactant, or a mixture of surfactants, having an overall HLB number of between 5 and 15; for application orally, nasally, rectally, or vaginally
10/19/2010US7815909 human tumor necrosis factor alpha (TNF) inhibitors; for rheumatoid arthritis, psoriatic arthritis or ankylosing spondilitis
10/19/2010US7815907 Antibodies to insulin-like growth factor I receptor
10/19/2010CA2621569C Solid salt forms of a pyrrole substituted 2-indolinone
10/19/2010CA2525245C Pyrazolo[3,4-b]pyridin-6-ones as gsk-3 inhibitors
10/19/2010CA2468314C The use of water-soluble lamarin in the treatment of cancer
10/19/2010CA2458699C Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
10/19/2010CA2451422C Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders
10/19/2010CA2448089C Thiolalkyl benzoic acid derivatives
10/19/2010CA2437409C Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/19/2010CA2417629C Derivatives of variolin b
10/19/2010CA2380022C Aromatic esters of camptothecins and methods to treat cancers
10/19/2010CA2379988C Enzyme catalyzed therapeutic activation
10/19/2010CA2374631C Benzene derivatives, process for their preparation and pharmaceutical compositions containing them
10/19/2010CA2362715C Quinazoline derivatives as angiogenesis inhibitors
10/19/2010CA2356845C Novel depsipeptide compound
10/19/2010CA2321455C Indole-3-propionic acids, salts and esters thereof used as medicaments
10/19/2010CA2147499C Prostate-specific membrane antigen
10/17/2010CA2701052A1 Method of cancer treatment
10/14/2010WO2010118419A2 Novel anti-aging agents and methods to identify them
10/14/2010WO2010118390A1 Checkpoint kinase 1 inhibitors for potentiating dna damaging agents
10/14/2010WO2010118347A2 O-linked glycan biosynthesis modulators
10/14/2010WO2010118339A2 Formulations of indole-3-carbinol derived antitumor agents with increased oral bioavailability
10/14/2010WO2010118309A2 Inhibitors of stat3 and uses thereof
10/14/2010WO2010118208A1 Benzoxazepin-4- (5h) -yl derivatives and their use to treat cancer
10/14/2010WO2010118207A1 Pyrazolo [1, 5-a] pyrimidine derivatives as mtor inhibitors
10/14/2010WO2010118203A2 Endosialin binding molecules
10/14/2010WO2010118200A2 Liposomal formulations of tocopheryl amides
10/14/2010WO2010118063A2 Therapeutic compositions and related methods of use
10/14/2010WO2010118013A1 Combination of cytidine-based antineoplastic drugs with cytidine deaminase inhibitor and use thereof in the treatment of cancer
10/14/2010WO2010118010A1 Combination of decitabine with cytidine deaminase inhibitor and use thereof in the treatment of cancer
10/14/2010WO2010118006A1 (2 ' -deoxy-ribofuranosyl) -1,3,4, 7-tetrahydro- (1,3) iazepin-2-0ne derivatives for treating cancer
1 ... 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 ... 2211